Annual EBITDA
$2.61B$346.11M+15.27%
Summary
- Current Value
- As of today, UHS annual EBITDA is $2.61B, up +15.27% on
- Historical Performance
- UHS annual EBITDA is up +59.03% over the past 3 years, up +39.91% over the past 5 years
- All-Time High Comparison
- UHS annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- UHS annual EBITDA is +59.03% above its 3-year low of $1.64B reached on an earlier date
- Sector Comparison
- UHS annual EBITDA is higher than 95.96% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.61B | +15.3% | +59.0% | +39.9% | +234.2% | |
| Quarterly EBITDA | $658.29M | +9.1% | +56.6% | +54.1% | +98.5% | |
| TTM EBITDA | $2.67B | +14.0% | +63.8% | +37.9% | +183.3% | |
| Price | $146.11 | -23.5% | +14.2% | -8.5% | +165.8% | |
| PE Ratio | 6.09 | -43.2% | -55.2% | -55.0% | -69.3% | |
| Annual Revenue | $17.36B | +9.7% | +29.6% | +50.2% | +211.9% | |
| Annual EPS | $23.10 | +37.3% | +152.7% | +109.4% | +887.0% | |
| $1.99B | +18.6% | +87.9% | +46.9% | +257.4% | ||
| Annual Net Income | $1.51B | +29.9% | +130.3% | +59.1% | +449.8% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.61B | at high | |
| 5Y | $2.61B | at high | |
| All | $2.61B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.64B | N/A | +59.0% |
| 5Y | $1.64B | +59.0% | |
| All | $16.54M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of UHS?
As of today, UHS annual EBITDA is $2.61B
What is 1-year change in UHS annual EBITDA?
UHS annual EBITDA is up +15.27% year-over-year
What is 3-year change in UHS annual EBITDA?
UHS annual EBITDA is up +59.03% over the past 3 years
How far is UHS annual EBITDA from its all-time high?
UHS annual EBITDA is currently at its all-time high
How does UHS annual EBITDA rank versus sector peers?
UHS annual EBITDA is higher than 95.96% of companies in Healthcare sector
When is UHS next annual earnings release?
As of today, the next annual earnings release for UHS has not been scheduled
Quarterly EBITDA
$658.29M$22.28M-3.27%
Summary
- Current Value
- As of today, UHS quarterly EBITDA is $658.29M, down -3.27% on
- Historical Performance
- UHS quarterly EBITDA is up +9.14% year-over-year, up +56.62% over the past 3 years
- All-Time High Comparison
- UHS quarterly EBITDA is currently -3.27% below its historical high of $680.57M set on
- 3-Year Low Comparison
- UHS quarterly EBITDA is +56.62% above its 3-year low of $420.32M reached on an earlier date
- Sector Comparison
- UHS quarterly EBITDA is higher than 95.76% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $658.29M | -3.3% | +9.1% | +56.6% | +54.1% | |
| Annual EBITDA | $2.61B | – | +15.3% | +59.0% | +39.9% | |
| TTM EBITDA | $2.67B | +2.1% | +14.0% | +63.8% | +37.9% | |
| Price | $146.11 | -29.1% | -23.5% | +14.2% | -8.5% | |
| PE Ratio | 6.09 | -31.6% | -43.2% | -55.2% | -55.0% | |
| Quarterly Revenue | $4.50B | +0.2% | +9.7% | +29.6% | +49.2% | |
| Quarterly EPS | $5.65 | -19.9% | +17.9% | +148.0% | +132.6% | |
| $502.86M | -2.8% | +10.6% | +80.4% | +70.1% | ||
| Quarterly Net Income | $358.68M | -19.9% | +11.5% | +121.1% | +72.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $680.57M | -3.3% | |
| 3Y | $680.57M | -3.3% | |
| 5Y | $680.57M | -3.3% | |
| All | $680.57M | -3.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $603.17M | N/A | +9.1% |
| 3Y | $420.32M | N/A | +56.6% |
| 5Y | $376.64M | +74.8% | |
| All | -$424.40M | +255.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of UHS?
As of today, UHS quarterly EBITDA is $658.29M
What is UHS quarterly EBITDA most recent change?
UHS quarterly EBITDA was down -3.27% on March 31, 2026
What is 1-year change in UHS quarterly EBITDA?
UHS quarterly EBITDA is up +9.14% year-over-year
How far is UHS quarterly EBITDA from its all-time high?
UHS quarterly EBITDA is currently -3.27% below its historical high of $680.57M set on December 31, 2025
How does UHS quarterly EBITDA rank versus sector peers?
UHS quarterly EBITDA is higher than 95.76% of companies in Healthcare sector
When is UHS next earnings release?
The next earnings release for UHS is on
TTM EBITDA
$2.67B$55.12M+2.11%
Summary
- Current Value
- As of today, UHS TTM EBITDA is $2.67B, up +2.11% on
- Historical Performance
- UHS TTM EBITDA is up +14.01% year-over-year, up +63.76% over the past 3 years
- All-Time High Comparison
- UHS TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- UHS TTM EBITDA is +63.76% above its 3-year low of $1.63B reached on an earlier date
- Sector Comparison
- UHS TTM EBITDA is higher than 95.85% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.67B | +2.1% | +14.0% | +63.8% | +37.9% | |
| Annual EBITDA | $2.61B | – | +15.3% | +59.0% | +39.9% | |
| Quarterly EBITDA | $658.29M | -3.3% | +9.1% | +56.6% | +54.1% | |
| Price | $146.11 | -29.1% | -23.5% | +14.2% | -8.5% | |
| PE Ratio | 6.09 | -31.6% | -43.2% | -55.2% | -55.0% | |
| TTM Revenue | $17.76B | +2.3% | +10.4% | +30.8% | +51.3% | |
| TTM EPS | $24.01 | +3.7% | +34.8% | +155.0% | +103.5% | |
| $2.04B | +2.4% | +16.8% | +94.6% | +44.1% | ||
| TTM Net Income | $1.55B | +2.5% | +27.0% | +131.9% | +52.6% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.67B | at high | |
| 3Y | $2.67B | at high | |
| 5Y | $2.67B | at high | |
| All | $2.67B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.34B | N/A | +14.0% |
| 3Y | $1.63B | N/A | +63.8% |
| 5Y | $1.59B | +68.3% | |
| All | -$197.00M | +1454.3% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of UHS?
As of today, UHS TTM EBITDA is $2.67B
What is UHS TTM EBITDA most recent change?
UHS TTM EBITDA was up +2.11% on March 31, 2026
What is 1-year change in UHS TTM EBITDA?
UHS TTM EBITDA is up +14.01% year-over-year
How far is UHS TTM EBITDA from its all-time high?
UHS TTM EBITDA is currently at its all-time high
How does UHS TTM EBITDA rank versus sector peers?
UHS TTM EBITDA is higher than 95.85% of companies in Healthcare sector
When is UHS next earnings release?
The next earnings release for UHS is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- UHS Official Website uhs.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/352915/000119312526071676/0001193125-26-071676-index.htm
- UHS Profile on Yahoo Finance finance.yahoo.com/quote/UHS
- UHS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/uhs